DocGo Inc. 2024 Annual Report (10-K) Summary
Business Context and Reporting Period
Company: DocGo Inc. (DCGO)
Reporting Period: Fiscal Year Ended December 31, 2024
Business Model: DocGo provides mobile healthcare services and medical transportation via a proprietary technology platform. Operations are divided into three segments: Mobile Health Services (in-home care, gap closure), Transportation Services (ambulance/non-emergency transport), and Corporate (shared services).
Geographic Reach: 31 U.S. states and the United Kingdom.
Key Operational Metric: In 2024, clinicians traveled over 8.8 million miles to facilitate 1.5 million patient interactions.
Key Financial Metrics (Year Ended Dec 31, 2024)
| Metric | 2024 Value | 2023 Value | Change |
|---|---|---|---|
| Net Revenue | $616.6 million | $624.3 million | (1.2%) |
| Net Income | $13.4 million | $10.0 million | +34.0% |
| Net Income Attributable to Stockholders | $20.0 million | $6.9 million | +189.9% |
| Operating Income | $28.7 million | $15.1 million | +90.1% |
| Gross Margin | 34.6% | 31.3% | +330 bps |
| Operating Cash Flow | $70.3 million | ($64.2 million) | Turnaround to Positive |
| Cash and Cash Equivalents | $89.2 million | $59.3 million | +50.4% |
| Debt (Revolving Credit Facility) | $30.0 million | $25.0 million | +20.0% |
| Working Capital | $182.7 million | $168.8 million | +8.2% |
Material Changes vs. Prior Period
- Revenue Decline in Mobile Health: Mobile Health Services revenue decreased 4.4% to $423.1 million, primarily due to the wind-down of migrant-related government contracts in New York which accelerated in Q3 and completed in Q4 2024.
- Transportation Growth: Transportation Services revenue increased 6.6% to $193.5 million, driven by a 13.7% increase in trip volumes, despite a slight decrease in average trip price.
- Profitability Improvement: Operating income nearly doubled (90.1% increase) due to cost reductions in subcontracted labor and medical supplies offsetting revenue declines, alongside a $9.4 million gain from the change in fair value of contingent liabilities.
- Impairment Charge: The company recorded an $8.3 million non-cash impairment charge related to finite-lived intangible assets (customer relationships) for the Cardiac RMS acquisition due to revised long-term forecasts.
- Cash Flow Turnaround: Operating cash flow swung from a $64.2 million outflow in 2023 to a $70.3 million inflow in 2024, largely driven by a $41.3 million decrease in accounts receivable as large municipal invoices were collected.
Guidance, Outlook, and Risks
Outlook: Management expects Mobile Health Services revenues to be lower in 2025 than in 2024 due to the continued wind-down of migrant-related projects. The company anticipates launching new projects and expanding existing ones but faces uncertainty regarding the timing of remaining contract wind-downs.
Key Risks:
- Customer Concentration: Two customers accounted for approximately 38% and 28% of total revenues in 2024. The loss of these contracts could materially impact the business.
- Government Contract Dependency: Government contracts represented approximately 72% of total revenue in 2024. These contracts are subject to funding changes, audits, and political shifts.
- Cybersecurity: The company experienced a cybersecurity incident in 2024 where a limited number of healthcare records were accessed. While no material impact was determined, the risk of future breaches remains high.
- Labor Costs: Labor expenses represent approximately 68% of revenues. Shortages of qualified healthcare professionals and wage inflation could compress margins.
Investor Verification Checklist
- Contract Renewals: Verify the status of the two largest customers (38% and 28% of revenue) and the timeline for the wind-down of remaining migrant-related contracts.
- Working Capital Cycle: Monitor the sustainability of the 2024 operating cash flow improvement, specifically the collection rates from municipal customers with long payment cycles.
- Debt Covenants: Review compliance with the Credit Agreement covenants (net leverage and interest coverage ratios) given the $30 million outstanding balance and variable interest rates.
- Intangible Asset Valuation: Assess the impact of the $8.3 million impairment on future earnings and the valuation assumptions for the Cardiac RMS acquisition.
- Cybersecurity Remediation: Confirm the status of the settlement regarding the 2024 data breach and the effectiveness of updated security protocols (SOC 2 Type II audit preparation).